diarrhea
lead
caus
death
neonat
calv
contribut
major
econom
loss
object
doubleblind
random
clinic
trial
evalu
effect
oral
inorgan
organ
zinc
supplement
treatment
neonat
diarrhea
calv
seventi
nine
day
old
male
holstein
calv
california
calf
ranch
block
random
one
treatment
within
h
first
onset
diarrhea
calv
receiv
daili
dose
either
placebo
compos
mg
zincfre
powder
mg
zinc
methionin
met
equival
mg
zinc
mg
zinc
oxid
zo
equival
mg
zinc
l
zincfre
oral
rehydr
solut
or
calv
treat
daili
normal
fecal
consist
maximum
day
upon
enrol
exit
calv
weigh
blood
fece
liver
biopsi
collect
trace
miner
analysi
fecal
sampl
enrol
exit
test
e
coli
cryptosporidium
spp
rotaviru
coronaviru
pretreat
liver
zinc
concentr
calv
placebo
zinc
met
zo
treatment
group
sem
sem
sem
mgkg
dri
weight
dw
respect
exit
liver
zinc
concentr
calv
placebo
zinc
met
zo
treatment
group
sem
sem
sem
mgkg
dri
weight
respect
although
statist
nonsignific
clinic
import
find
identifi
zinc
met
zo
treatment
calv
treat
zinc
met
gain
averag
gday
diarrhea
episod
compar
weight
loss
gday
averag
placebotr
calv
power
calv
treat
zo
time
higher
hazard
clinic
cure
compar
calv
placebo
group
manuscript
repres
thesi
submit
dr
glover
univers
california
davi
school
veterinari
medicin
partial
fulfil
requir
master
prevent
veterinari
medicin
degre
open
access
cc
byncnd
licens
ad
glover
et
al
prevent
veterinari
medicin
power
calv
fecal
posit
cryptosporidium
spp
enrol
treat
zinc
met
higher
odd
test
neg
exit
compar
placebo
calv
odd
ratio
contrast
calv
treat
zo
tend
recov
fecal
score
one
day
earlier
compar
calv
treat
placebo
vs
current
trial
identifi
clinic
import
find
warrant
research
investig
zinc
therapeut
effect
calf
diarrhea
consider
econom
loss
may
incur
neonat
diseas
calf
rear
prewean
heifer
wean
heifer
die
primarili
due
diarrhea
gastrointestin
ill
nahm
similarli
pediatr
diarrhea
lead
caus
death
children
age
year
develop
countri
estim
caus
million
death
annual
bhutta
et
al
hoqu
et
al
base
numer
random
clinic
trial
world
health
organ
recommend
zinc
supplement
oral
rehydr
solut
decreas
durat
sever
infant
diarrhea
bhutta
et
al
faruqu
et
al
penni
et
al
infant
diarrhea
day
significantli
lower
serum
zinc
level
compar
healthi
infant
infant
nongastrointestin
ill
naveh
et
al
suggest
gastrointestin
loss
zinc
hoqu
et
al
zincsuppl
or
also
result
increas
recoveri
rate
reduc
mortal
reduct
use
antibiot
bhandari
et
al
bhutta
et
al
bhutta
et
al
although
exact
underli
mode
action
zinc
still
known
hoqu
et
al
mucosalprotect
role
enhanc
cellmedi
immun
modif
intralumin
electrolyt
secret
absorpt
mechan
propos
atia
buchman
fischer
walker
et
al
hoqu
et
al
similar
benefit
zincsuppl
or
diarrhea
calv
could
significantli
impact
econom
sustain
product
system
reduc
antibiot
use
treatment
calf
diarrhea
zinc
studi
demonstr
benefici
effect
piglet
rat
calf
growth
fetal
develop
graham
et
al
graham
et
al
owusuasiedu
et
al
howev
therapeut
use
zinc
calv
diarrhea
studi
comparison
inorgan
organ
formul
zinc
zinc
oxid
zo
zinc
methionin
met
respect
warrant
differ
zinc
bioavail
wedekind
et
al
greater
effect
inorgan
zinc
formul
treat
calf
diarrhea
compar
organ
formul
may
evid
zinc
local
intralumin
mode
action
given
poor
absorpt
intestin
absorpt
coeffici
zo
compar
zinc
met
cousin
hand
zinc
met
found
effect
zo
treat
diarrhea
may
evid
system
mode
action
given
greater
bioavail
zinc
met
compar
zo
addit
zinc
antagonist
copper
nrc
comprehens
assess
trace
miner
necessari
administ
zinc
calv
hypothesi
blockrandom
doubleblind
clinic
trial
neonat
holstein
calv
diarrhea
supplement
either
zinc
met
zo
experi
reduc
day
recoveri
diarrhea
reduc
mortal
reduc
weight
lost
diarrhea
episod
compar
placebo
treat
calv
object
clinic
trial
compar
effect
daili
dose
zo
zinc
met
equival
mg
zinc
placebo
maximum
day
fecal
output
recoveri
otherwis
untreat
dayold
holstein
bull
calv
neonat
diarrhea
california
calf
ranch
secondari
object
assess
effect
zinc
met
zo
serum
liver
zinc
copper
iron
concentr
procedur
approv
univers
california
davi
institut
anim
care
use
committe
protocol
number
clinic
trial
conduct
june
septemb
larg
california
calf
ranch
san
joaquin
valley
hous
approxim
holstein
calv
prewean
age
calv
enrol
includ
male
holstein
develop
diarrhea
first
time
day
age
calv
exclud
studi
previou
incid
diarrhea
sinc
birth
sign
diseas
diarrhea
umbil
abscess
pneumonia
mening
previous
treat
antimicrobi
drug
calv
diarrhea
identifi
veterinarian
ag
prior
enrol
due
lack
estim
neonat
calv
sampl
size
estim
base
differ
serum
zinc
level
infant
without
diarrhea
increas
serum
zinc
level
post
treatment
calv
assum
similar
infant
naveh
et
al
henc
sampl
size
calcul
detect
statist
signific
differ
serum
zinc
concentr
treat
calv
mean
sd
gdl
placebo
calv
gdl
power
level
signific
total
calv
per
group
requir
allow
loss
followup
total
calv
per
group
n
total
requir
studi
prior
initi
studi
zinc
concentr
water
calf
starter
grain
milk
replac
electrolyt
tabl
baselin
clinic
paramet
rectal
temperatur
weight
attitud
neonat
holstein
calv
enrol
prior
treatment
one
three
treatment
group
placebo
zinc
methionin
met
zinc
oxid
zo
doubleblind
blockrandom
clinic
trial
effect
zinc
treatment
diarrhea
b
signific
differ
mean
within
row
p
c
attitud
score
calf
stand
bright
alert
respons
good
suckl
reflex
calf
stood
stimul
moder
suckl
reflex
calf
recumb
stand
stimul
weak
absent
suckl
reflex
fecal
zinc
serum
zinc
liver
zinc
copper
iron
concentr
express
mean
neonat
holstein
calv
treatment
placebo
zinc
methionin
met
zinc
oxid
zo
doubleblind
blockrandom
clinic
trial
effect
zinc
treatment
diarrhea
b
mean
differ
letter
within
row
significantli
differ
p
c
fecal
zinc
mgkg
dw
serum
zinc
mgl
liver
zinc
copper
iron
mgkg
dw
liver
zinc
iron
concentr
pre
post
treatment
liver
biopsi
sampl
insuffici
accur
zinc
iron
determin
two
sampl
thu
two
calv
exclud
liver
zinc
iron
enrol
exit
analysi
powder
determin
calv
calf
ranch
receiv
diet
hutch
consist
l
milk
replac
twice
daili
free
access
water
calf
starter
grain
mix
electrolyt
powder
proprietari
mix
submit
heavi
metal
analysi
contain
ppm
iron
heavi
metal
detect
pretrial
sampl
collect
water
contain
detect
zinc
calf
starter
grain
contain
mgkg
zinc
dm
milk
replac
mgkg
zinc
dm
calv
random
veterinarian
ag
one
treatment
block
rang
calv
depend
number
calv
elig
enrol
day
random
scheme
gener
use
microsoft
excel
differ
veterinarian
sa
treatment
placebo
zinc
met
zo
place
ml
lockinglid
microcentrifug
tube
polypropylen
snapcap
fisher
scientif
pittsburgh
pa
label
sa
treatment
alloc
administr
data
record
perform
ag
blind
true
treatment
complet
trial
success
blind
random
produc
compar
group
evalu
compar
baselin
valu
enrol
use
anova
clinic
paramet
tabl
trace
miner
concentr
tabl
calv
receiv
singl
daili
oral
dose
either
mg
zincfre
placebo
electrolyt
powder
use
make
or
group
mg
zinc
met
equival
mg
zinc
group
mg
zo
equival
mg
zinc
group
dissolv
l
zincfre
or
solut
dose
mg
zinc
per
day
base
ratio
human
zinc
nutrient
requir
nhmrc
zinc
supplement
or
bhandari
et
al
bhutta
et
al
patel
et
al
verifi
less
ratio
calv
recommend
zinc
intak
nrc
toxic
level
graham
et
al
graham
et
al
upon
enrol
calf
weigh
kg
salter
brecknel
scale
fairmont
mn
receiv
complet
physic
examin
part
physic
examin
rectal
temperatur
c
fecal
consist
attitud
score
calf
fecal
output
score
singl
veterinarian
ag
adapt
fecal
score
univers
wisconsin
calf
health
score
chart
http
calf
health
score
chartpdf
fecal
sampl
solid
semiformedloos
wateri
assign
respect
decis
made
merg
origin
chart
semiform
loos
categori
consist
given
potenti
difficulti
distinguish
rais
slat
wooden
floor
calf
hutch
similar
simpl
score
system
calf
attitud
follow
calf
attitud
score
stand
bright
alert
respons
good
suckl
reflex
score
calf
stood
stimul
moder
suckl
reflex
score
calf
recumb
stand
stimul
weak
absent
suckl
reflex
enrol
fecal
consist
attitud
trial
calv
record
everi
day
fecal
venou
blood
sampl
collect
enrol
everi
day
thereaft
exit
trial
addit
liver
biopsi
swanson
et
al
collect
calf
enrol
exit
calv
enrol
follow
everi
day
physic
exam
blood
fecal
sampl
collect
continu
receiv
alloc
treatment
clinic
sign
resolv
normal
rectal
temperatur
diarrhea
h
attitud
score
maximum
day
time
calv
elig
exit
liver
biopsi
collect
describ
elsewher
swanson
et
al
briefli
hair
remov
rib
right
intercost
space
site
disinfect
use
povidon
iodin
scrub
alcohol
povidon
iodin
solut
incis
site
block
ml
lidocain
use
gaug
inch
needl
skin
thorac
muscl
stab
incis
made
carbon
steel
surgic
blade
approxim
cm
dorsal
midlin
intercost
space
gaug
cm
steril
carefus
trucut
biopsi
needl
san
diego
ca
insert
incis
liver
biopsi
collect
rapid
act
adhes
use
skin
closur
liver
biopsi
immedi
place
ml
lockinglid
microcentrifug
tube
polypropylen
snapcap
store
ice
period
h
store
c
submiss
test
particip
laboratori
blood
collect
jugular
vein
use
gaug
inch
needl
place
tube
bd
vacutain
franklin
nj
either
contain
k
edta
assess
pack
cell
volum
pcv
total
plasma
protein
tpp
concentr
special
trace
element
tube
royal
blue
top
tube
rbtt
trace
miner
analysi
sampl
pcv
measur
use
microhematocrit
centrifug
tpp
gdl
measur
use
reichertjung
refractomet
trace
element
blood
tube
spun
centrifug
min
serum
decant
ml
lockinglid
microcentrifug
tube
polypropylen
snapcap
store
c
fecal
sampl
place
steril
polypropylen
centrifug
tube
store
c
fecal
serum
sampl
test
within
month
collect
fecal
sampl
collect
enrol
exit
test
dairi
epidemiolog
laboratori
vmtrc
cryptosporidium
spp
oocyst
bovin
rotaviru
coronaviru
e
coli
use
commerci
kit
highli
specif
greater
sensit
coronaviru
e
coli
rotaviru
biovet
quebec
canada
robert
et
al
thorn
et
al
fecal
sampl
initi
test
salmonella
due
histor
low
preval
salmonella
bimonthli
screen
routin
conduct
studi
calf
ranch
calv
die
studi
necropsi
determin
caus
death
toxicolog
test
conduct
california
anim
health
food
safeti
cahf
laboratori
davi
ca
heavi
metal
analysi
liver
sampl
approxim
g
biopsi
g
carcass
liver
place
steril
plastic
nasco
whirlpak
thermo
fisher
scientif
inc
wilmington
store
c
analysi
tissu
sampl
ship
frozen
cahf
toxicolog
laboratori
order
determin
percent
moistur
tissu
sampl
place
dri
oven
c
weigh
daili
constant
weight
indic
complet
remov
moistur
liver
sampl
digest
nitric
acid
analyz
lead
manganes
iron
mercuri
arsen
molybdenum
zinc
copper
cadmium
induct
coupl
argon
plasma
emiss
spectrometri
icap
arl
accuri
model
thermo
optek
corpor
franklin
accuraci
icap
measur
analyz
standard
refer
materi
srm
bovin
liver
nation
bureau
standard
technolog
srm
lobster
hepatopancrea
nation
research
council
canada
data
accept
valu
standard
refer
materi
fell
within
standard
deviat
certifi
refer
valu
metal
concentr
determin
wet
weight
basi
convert
concentr
per
dri
weight
dimension
analysi
follow
heavi
metal
mgkg
dri
mass
heavi
metal
mgkg
wet
weight
moistur
calv
exclud
liver
miner
analysi
liver
biopsi
submit
less
mg
wet
weight
feed
sampl
dm
digest
nitric
acid
analyz
lead
manganes
cadmium
copper
iron
zinc
molybdenum
arsen
mercuri
icap
accuraci
icap
result
measur
analyz
srm
overspik
feed
sampl
similar
matrix
srm
includ
dogfish
liver
nation
research
council
canada
lobster
hepatopancrea
nation
research
council
canada
data
accept
analyz
srm
valu
within
standard
deviat
certifi
refer
valu
overspik
recoveri
zinc
copper
iron
magnesium
sodium
phosphoru
calcium
potassium
concentr
measur
serum
sampl
precipit
protein
use
icap
fison
accuri
model
thermo
optek
corpor
franklin
accuraci
icap
result
element
measur
analyz
qualiti
assur
sera
obtain
veterinari
laboratori
associ
qualiti
assur
program
genzym
diagnost
blain
md
usa
data
accept
analyz
qualiti
assur
serum
valu
within
standard
deviat
refer
valu
statist
analys
perform
use
ibm
spss
statist
softwar
version
somer
ny
stata
mp
colleg
station
tx
statist
differ
determin
level
signific
use
intent
treat
analysi
anova
use
compar
calv
enrol
treatment
group
prior
administr
first
treatment
respect
rectal
temperatur
c
weight
kg
attitud
score
fecal
serum
liver
zinc
copper
iron
concentr
anova
use
compar
mean
daili
weight
chang
g
treatment
group
mean
daili
weight
chang
calcul
differ
exit
enrol
weight
divid
number
day
calf
trial
anova
use
compar
calv
treatment
group
exit
trial
respect
mean
concentr
fecal
zinc
mgkg
dri
weight
dw
serum
zinc
mgl
liver
zinc
copper
iron
mgkg
dw
kaplanmei
analysi
use
determin
mean
day
clinic
cure
calv
test
posit
fecal
elisa
kit
enrol
cryptosporidium
spp
e
coli
coronaviru
rotaviru
normal
fecal
score
least
h
calv
die
fecal
score
greater
exit
censor
cox
proport
hazard
ph
regress
analysi
use
estim
compar
hazard
clinic
cure
assess
everi
day
proport
hazard
assumpt
clinic
cure
hazard
independ
time
assess
use
logminuslog
lml
surviv
plot
gener
treatment
group
variabl
placebo
group
refer
full
cox
model
hazard
clinic
cure
calf
enrol
diarrhea
summar
nonneg
unspecifi
baselin
hazard
independ
variabl
compos
regress
coeffici
estim
zm
zinc
met
zo
compar
placebo
x
respect
observ
covari
valu
cox
proport
hazard
regress
model
estim
clinic
cure
pathogen
enrol
power
calcul
perform
nonsignific
model
use
global
logrank
test
assum
level
signific
baselin
cumul
failur
probabl
observ
placebo
group
model
estim
hazard
ratio
independ
variabl
barthel
et
al
enrol
exit
fecal
sampl
test
pathogen
make
exact
time
microbiolog
cure
unknown
henc
logist
regress
use
estim
compar
odd
microbiolog
cure
exit
fecal
score
day
treatment
treatment
group
microbiolog
cure
determin
calf
test
neg
four
pathogen
exit
e
coli
cryptosporidium
spp
coronaviru
rotaviru
addit
logist
regress
model
estim
microbiolog
cure
pathogen
enrol
power
calcul
perform
model
nonsignific
coeffici
assum
level
signific
observ
sampl
size
proport
calv
attain
respect
outcom
model
total
calv
enrol
calv
group
placebo
calv
group
zinc
met
group
zo
trial
calv
drank
morn
afternoon
two
quart
daili
milk
bottl
except
two
calv
die
enrol
block
ad
calv
addit
calf
enrol
group
last
day
bring
total
enrol
calv
total
calv
exclud
analys
includ
one
calf
mistakenli
enrol
group
normal
fecal
consist
two
calv
group
one
die
immedi
enrol
necropsi
reveal
abomas
torsion
anoth
enrol
umbil
abscess
two
calv
group
one
die
enrol
necropsi
reveal
serou
atrophi
fat
moribund
enrol
sever
system
ill
unabl
drink
milk
electrolyt
treatment
calv
studi
die
trial
one
group
placebo
gross
lesion
infarct
perfor
ulcer
cecum
one
group
zinc
met
enter
one
group
zo
bilater
bronchopneumonia
evid
periton
associ
liver
biopsi
calv
fig
mean
confid
interv
daili
weight
chang
gram
neonat
holstein
calv
diagnos
diarrhea
randomli
alloc
placebo
zinc
methionin
met
zinc
oxid
zo
treatment
doubleblind
blockrandom
clinic
trial
studi
effect
zinc
treatment
diarrhea
submit
necropsi
histolog
formalinfix
pancrea
calf
die
reveal
damag
exocrin
pancrea
therefor
evid
zinc
toxicosi
gabrielson
et
al
smith
embl
remain
calv
treat
daili
either
placebo
zinc
met
zo
formul
remov
trial
develop
normal
fecal
score
end
day
supplement
period
baselin
comparison
treatment
group
enrol
show
signific
differ
rectal
temperatur
c
p
enrol
weight
kg
p
attitud
p
tabl
statist
signific
differ
fecal
zinc
p
serum
zinc
p
liver
zinc
p
copper
p
iron
p
concentr
enrol
tabl
weight
data
calv
enrol
exit
avail
analysi
statist
signific
differ
mean
daili
weight
chang
calv
three
treatment
group
p
howev
calv
treat
zinc
met
experienc
mean
daili
weight
gain
g
sd
compar
mean
daili
weight
loss
g
sd
placebo
group
mean
daili
weight
loss
g
sd
zo
group
fig
power
estim
comparison
mean
daili
weight
loss
placebo
group
mean
daili
weight
gain
zinc
met
estim
sampl
size
calv
per
group
requir
find
statist
signific
differ
use
power
data
calv
avail
fecal
serum
zinc
copper
iron
analysi
exit
data
calv
exist
die
trial
serum
fecal
sampl
abl
collect
prior
death
exit
signific
differ
among
calv
three
treatment
group
regard
fecal
copper
p
iron
p
exit
calv
treat
zinc
met
significantli
higher
fecal
zinc
concentr
mgkg
dw
p
compar
placebo
calv
signific
differ
among
calv
supplement
zinc
met
zo
p
tabl
exit
signific
differ
among
calv
three
treatment
group
regard
serum
copper
p
iron
p
calv
treat
zinc
met
significantli
higher
serum
zinc
concentr
compar
placebo
group
mgl
vs
mgl
p
signific
differ
among
calv
treat
zinc
met
zo
p
tabl
liver
zinc
analysi
result
exist
calv
enrol
three
calv
die
trial
thu
calv
avail
liver
zinc
analysi
exit
calv
die
necropsi
gross
histopatholog
sign
suggest
overexposur
zinc
gabrielson
et
al
smith
embl
liver
zinc
dw
concentr
calv
treat
zinc
met
zo
differ
significantli
calv
treat
placebo
p
mean
sem
dw
liver
zinc
concentr
exit
placebo
zinc
met
zo
group
mgkg
respect
calv
treat
zinc
met
higher
dw
liver
zinc
mean
concentr
compar
placebo
group
although
significantli
higher
p
tabl
copper
liver
concentr
avail
calv
enrol
calv
exit
three
calv
die
trial
thu
liver
biopsi
sampl
avail
analysi
exit
remain
calv
less
mg
tissu
mass
biopsi
henc
miss
liver
heavi
metal
concentr
exit
mean
sem
dw
liver
copper
concentr
exit
placebo
zinc
met
zo
group
mgkg
respect
signific
differ
three
group
regard
liver
copper
dw
concentr
exit
p
tabl
liver
iron
concentr
avail
calv
enrol
calv
exit
three
calv
die
trial
thu
liver
biopsi
sampl
avail
analysi
exit
likewis
mean
sem
dw
liver
iron
concentr
exit
placebo
zinc
met
zo
group
mgkg
respect
signific
differ
liver
iron
dw
concentr
among
three
treatment
group
exit
p
tabl
total
calv
includ
kaplanmei
surviv
analysi
mean
day
clinic
cure
signific
differ
mean
day
recoveri
calv
treat
either
placebo
zinc
met
zo
respect
p
tabl
although
signific
differ
hazard
clinic
cure
treatment
group
calv
treat
zo
time
higher
hazard
clinic
cure
exit
fecal
score
compar
calv
placebo
group
p
power
clinic
cure
pathogen
enrol
calv
posit
e
coli
enrol
placebo
group
zinc
met
zo
group
attain
clinic
cure
henc
surviv
analysi
possibl
although
signific
hazard
ratio
compar
clinic
cure
calv
posit
cryptosporidium
spp
coronaviru
enrol
treat
zo
comparison
placebo
greater
power
respect
howev
case
calv
test
posit
rotaviru
enrol
either
zinc
met
zo
group
power
result
logist
regress
model
microbiolog
cure
summar
tabl
although
statist
signific
odd
test
neg
four
pathogen
exit
time
higher
calv
treat
zinc
met
compar
calv
treat
placebo
p
power
pathogen
specif
cure
calv
test
posit
enrol
coronaviru
n
e
coli
n
test
neg
exit
fecal
score
day
treatment
similarli
calv
test
posit
rotaviru
enrol
test
posit
exit
fecal
score
day
treatment
henc
logist
regress
analys
microbiolog
cure
calv
test
posit
latter
pathogen
possibl
contrast
calv
test
posit
cryptosporidium
spp
enrol
treat
zinc
met
time
higher
odd
fecal
elisa
neg
exit
compar
placebo
group
howev
differ
also
signific
p
power
data
collect
current
trial
show
daili
zinc
dose
mg
result
zinc
toxicosi
copper
iron
defici
current
trial
result
provid
evid
benefici
effect
either
zinc
met
zo
treatment
diarrhea
neonat
holstein
calv
contrast
studi
infant
report
signific
reduct
diarrheaassoci
mortal
oral
zinc
supplement
bhandari
et
al
bhutta
et
al
differ
find
pediatr
trial
calf
trial
may
explain
differ
pathogen
diseas
sever
sinc
pediatr
research
conduct
diseas
infant
sever
clinic
sign
greater
risk
mortal
compar
calv
trial
explan
lack
signific
differ
among
treatment
group
may
due
subtherapeut
zinc
dose
trial
dose
provid
mg
avail
zincday
small
sampl
size
inde
estim
power
analys
current
data
show
evid
low
sampl
size
exit
calv
treat
zinc
met
significantli
higher
fecal
serum
zinc
concentr
compar
placebo
treat
group
howev
signific
differ
liver
zinc
concentr
exit
among
three
treatment
group
stratifi
analysi
durat
treatment
day
show
calv
treatment
day
supplement
zinc
met
significantli
higher
fecal
zinc
concentr
compar
placebo
treat
calv
differ
liver
serum
zinc
concentr
among
three
group
data
shown
total
zinc
measur
fece
mgkg
dw
thu
abl
differenti
differ
form
zinc
known
fecal
excret
zinc
increas
intak
zinc
increas
human
possibl
zinc
met
absorb
metabol
form
zinc
excret
via
intestin
bile
cousin
spencer
et
al
trend
continu
calv
treat
day
calv
trial
day
supplement
zinc
met
significantli
higher
serum
liver
zinc
concentr
placebo
treat
calv
find
consist
increas
bioavail
zinc
met
compar
zo
absorpt
coeffici
zinc
met
compar
zo
report
cousin
known
bovin
fetu
complet
depend
placenta
gestat
suppli
essenti
trace
element
hidirogl
knipfel
addit
liver
zinc
mean
sem
concentr
vari
mgkg
dw
day
gestat
mgkg
dw
day
gestat
abdelrahman
kincaid
zinc
concentr
bovin
colostrum
milk
gml
gml
respect
current
studi
calv
fed
formul
milk
replac
contain
mgkg
zinc
dw
equival
g
zincml
fed
abdelrahman
kincaid
nation
research
council
nrc
daili
zinc
recommend
calv
mgkg
total
diet
signific
effect
age
liver
zinc
concentr
calv
liver
zinc
concentr
decreas
time
birth
puschner
et
al
low
level
found
colostrum
milk
replac
may
reflect
adequ
tissu
reserv
zinc
bovin
neonat
abdelrahman
kincaid
nrc
thu
calv
born
adequ
zinc
store
liver
requir
much
diet
trial
dose
mg
zincday
like
low
effect
exit
trial
calv
treat
zinc
met
significantli
higher
fecal
p
serum
zinc
p
concentr
compar
placebo
group
despit
zinc
met
bioavail
excret
fece
indic
calv
adequ
zinc
bodi
store
trial
dose
may
low
effect
current
trial
zinc
dose
mgday
holstein
calv
age
day
result
zinc
toxicosi
known
clinic
sign
death
zinc
toxicosi
occur
prerumin
calv
fed
g
zincg
mgkg
diet
day
graham
et
al
previou
studi
day
old
male
holstein
calv
fed
milk
replac
contain
mgkg
zinc
weight
gain
dm
intak
feed
effici
reduc
mgkg
level
jenkin
hidirogl
calv
current
trial
fed
formul
milk
replac
made
calf
ranch
contain
mgkg
zinc
addit
addit
mg
zinc
result
total
zinc
level
well
toxic
dose
gg
zinc
assum
fed
gallon
kg
milk
per
day
approxim
total
zinc
intak
level
kg
mg
mg
mg
previou
research
indic
calv
requir
anywher
mgkg
zinc
total
diet
maintain
adequ
plasma
level
mgkg
dietari
zinc
may
requir
accord
nrc
herrick
nrc
thu
therapeut
dose
known
age
holstein
calv
inform
suggest
may
wide
rang
among
toler
therapeut
toxic
level
import
find
current
studi
calv
treat
either
zinc
met
zo
experi
clinic
laboratori
evid
zinc
toxic
mean
sem
liver
zinc
wet
weight
concentr
placebo
zinc
met
zo
treat
calv
exit
mgkg
respect
report
mean
liver
zinc
wet
weight
concentr
mgkg
neonat
holstein
calv
clinic
sign
zinc
toxicosi
graham
et
al
report
calv
one
year
age
without
clinic
sign
zinc
defici
toxicosi
accept
liver
zinc
concentr
rang
mgkg
wet
weight
puschner
et
al
base
data
calv
trial
liver
zinc
concentr
suggest
zinc
defici
mgkg
wet
weight
toxicosi
possibl
wide
rang
liver
zinc
concentr
first
three
week
life
birth
wean
wean
breed
age
supplement
zinc
diet
calv
interact
metal
especi
copper
iron
must
consid
graham
et
al
calv
measur
liver
copper
concentr
exit
trial
mean
sem
liver
copper
wet
weight
concentr
placebo
zinc
met
zo
treat
calv
mgkg
respect
report
newborn
calv
without
clinic
sign
copper
defici
toxicosi
expect
liver
copper
concentr
rang
mgkg
wet
weight
mgkg
dw
puschner
et
al
calv
placebo
zinc
met
zo
treatment
group
mean
liver
copper
dw
valu
higher
rang
exit
indic
zinc
supplement
caus
defici
liver
copper
concentr
current
trial
calv
treat
zinc
met
mean
daili
gain
g
compar
daili
loss
two
treatment
group
observ
record
trial
prove
calv
treat
zinc
met
tend
gain
rather
lose
weight
direct
point
estim
weight
chang
group
worth
investig
sampl
size
current
studi
permit
power
detect
signific
daili
weight
gain
zinc
met
group
compar
placebo
group
discuss
earlier
sampl
size
determin
studi
base
studi
infant
detect
statist
signific
differ
children
gastrointestin
ill
healthi
infant
infant
diseas
diarrhea
naveh
et
al
approach
may
inappropri
detect
signific
differ
neonat
holstein
calv
given
studi
find
sampl
size
need
detect
statist
signific
differ
mean
daili
weight
chang
placebo
group
gday
sd
zinc
met
group
gday
sd
given
power
calv
per
group
number
easili
attain
dairi
calf
ranch
california
although
data
collect
prove
posit
associ
zo
clinic
cure
calv
supplement
zo
higher
hazard
clinic
cure
compar
placebo
addit
hazard
clinic
cure
calv
test
posit
cryptosporidium
spp
coronaviru
enrol
treat
zo
greater
respect
hazard
calv
treat
placebo
respect
microbiolog
cure
calv
test
posit
cryptosporidium
spp
enrol
treat
zinc
met
time
higher
odd
microbiolog
cure
pathogen
test
neg
exit
calv
placebo
group
given
magnitud
associ
respect
power
estim
studi
requir
investig
effect
zinc
met
microbiolog
prevent
cure
cryptosporidiosi
dairi
calv
lethal
dose
ld
zinc
formul
differ
age
group
would
need
estim
formal
toxic
studi
guid
dairi
industri
use
optim
dose
zinc
therapeut
treatment
calf
diarrhea
avoid
accident
intox
current
studi
result
limit
find
clinic
import
differ
treatment
group
statist
signific
furthermor
studi
conduct
larg
calf
ranch
california
may
differ
prewean
calf
manag
dairi
import
differ
may
includ
less
variabl
prewean
calf
diet
close
follow
standard
protocol
calf
health
monitor
treatment
despit
limit
result
current
doubl
blind
clinic
trial
show
may
posit
impact
zinc
calf
health
manag
includ
decreas
use
antimicrobi
drug
first
random
clinic
trial
test
effect
daili
oral
zinc
supplement
neonat
holstein
calv
diarrhea
data
collect
current
trial
provid
evid
benefici
effect
daili
oral
mg
zinc
either
zinc
met
zo
treatment
day
recoveri
fecal
consist
microbiolog
clinic
cure
holstein
calv
diarrhea
total
daili
dose
mg
avail
zinc
result
zinc
toxic
miner
defici
although
statist
signific
current
trial
identifi
clinic
import
differ
weight
chang
cours
diarrhea
calv
potenti
interest
contrast
effect
organ
versu
inorgan
zinc
formul
clinic
microbi
cure
neonat
holstein
calv
differ
pathogen
research
center
school
veterinari
medicin
univers
california
davi
author
thank
calf
ranch
manag
personnel
assist
